Literature DB >> 19556907

Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy.

Vic J Verwaal1.   

Abstract

Cytoreduction followed by hyperthermic intraperitoneal chemotherapy is a treatment option for peritoneal surface malignancies in The Netherlands. This treatment has been available for more than 10 years. Therefore, long-term results on survival and quality of life can now be studied. With these results, the true long-term benefits of this new management strategy can be determined.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19556907     DOI： 10.1097/PPO.0b013e3181a58d7c

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


  16 in total

1.  No-incision (NOTES) versus single-incision (single-port) surgery for access to sites of peritoneal carcinomatosis: a back-to-back animal study.

Authors:  Yamina Ladjici; Marc Pocard; Philippe Marteau; Patrice Valleur; Xavier Dray
Journal:  Surg Endosc       Date:  2012-04-05       Impact factor: 4.584

2.  Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in Mainland China.

Authors:  Tao Suo; Haile Mahteme; Xin-Yu Qin
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

3.  Small bowel emergency surgery: literature's review.

Authors:  Carlo Vallicelli; Federico Coccolini; Fausto Catena; Luca Ansaloni; Giulia Montori; Salomone Di Saverio; Antonio D Pinna
Journal:  World J Emerg Surg       Date:  2011-01-07       Impact factor: 5.469

4.  [Hyperthermic intraperitoneal chemotherapy in the German DRG system. Analysis of case cost calculations of a maximum care university].

Authors:  M Kilian; R Hammerich; C Langelotz; W Raue; N Tsilimparis; B Rau; J Hartmann
Journal:  Chirurg       Date:  2010-11       Impact factor: 0.955

5.  A new standard of care for the management of peritoneal surface malignancy.

Authors:  F Mohamed; T Cecil; B Moran; P Sugarbaker
Journal:  Curr Oncol       Date:  2011-04       Impact factor: 3.677

6.  Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma.

Authors:  Yasmin M Ali; Joseph Sweeney; Perry Shen; Konstantinos I Votanopoulos; Richard McQuellon; Katie Duckworth; Kathleen C Perry; Greg Russell; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2019-05-08       Impact factor: 5.344

7.  Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study.

Authors:  Olaf Sørensen; Anders Andersen; Harald Olsen; Kristian Alexandr; Per Olaf Ekstrøm; Karl-Erik Giercksky; Kjersti Flatmark
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

8.  Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach?

Authors:  Paul H Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-07-19       Impact factor: 2.260

9.  A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion.

Authors:  Michelle Haslinger; Valerie Francescutti; Kristopher Attwood; Judith Andrea McCart; Marwan Fakih; John M Kane; Joseph J Skitzki
Journal:  Cancer Med       Date:  2013-04-16       Impact factor: 4.452

10.  Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy.

Authors:  Yutaka Yonemura; Emel Canbay; Haruaki Ishibashi
Journal:  ScientificWorldJournal       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.